The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
Authors:
Open Access
- 12 November 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12
Abstract
Glucocorticoids are drugs that are widely used to suppress inflammation and the activation of the immune system. However, the prolonged use or at high doses of glucocorticoid can result in adverse side effects including osteoporosis, bone loss, and an increased risk of fracture. A number of compounds derived from natural plant sources have been reported to exert anti-inflammatory activity by interacting with the glucocorticoid receptor (GR), likely owing to their chemical similarity to glucocorticoids, or by regulating GR, without a concomitant risk of treatment-related side effects such as osteoporosis. Other herbal compounds can counteract the pathogenic processes underlying glucocorticoid-induced osteoporosis (GIOP) by regulating homeostatic bone metabolic processes. Herein, we systematically searched the PubMed, Embase, and Cochrane library databases to identify articles discussing such compounds published as of May 01, 2021. Compounds reported to exert anti-inflammatory glucocorticoid-like activity without inducing GIOP include escin, ginsenosides, and glycyrrhizic acid, while compounds reported to alleviate GIOP by improving osteoblast function or modulating steroid hormone synthesis include tanshinol and icariin.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 77 references indexed in Scilit:
- Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylationCell Death & Disease, 2013
- Icariin Protects Against Glucocorticoid-Induced Osteoporosis In Vitro and Prevents Glucocorticoid-Induced Osteocyte Apoptosis In VivoCell Biochemistry and Biophysics, 2013
- Glycyrrhizic acid and 18β-glycyrrhetinic acid recover glucocorticoid resistance via PI3K-induced AP1, CRE and NFAT activationPhytomedicine, 2013
- Salvianolic Acid B Prevents Bone Loss in Prednisone-Treated Rats through Stimulation of Osteogenesis and Bone Marrow AngiogenesisPLOS ONE, 2012
- Potent anti-inflammatory agent escin does not affect the healing of tibia fracture and abdominal wound in an animal modelExperimental and Therapeutic Medicine, 2012
- Advances in Glucocorticoid-Induced OsteoporosisCurrent Rheumatology Reports, 2011
- Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone DensityEndocrinology, 2006
- Glucocorticoids suppress bone formation via the osteoclastJournal of Clinical Investigation, 2006
- Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1Experimental & Molecular Medicine, 2006
- Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblastsBiochemical and Biophysical Research Communications, 2005